Jul 14, 2024, 07:59
New drug from Erasca in combination with cetuximab – Chordoma Foundation
Chordoma Foundation shared a post on X:
“Promising results have emerged from a Phase 1 clinical trial testing a new drug from Erasca called ERAS-601 alone and in combination with cetuximab: Nearly all of the 13 chordoma patients enrolled had some tumor shrinkage.”
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Oct 27, 2024, 14:33
Oct 27, 2024, 14:23
Oct 27, 2024, 14:17
Oct 27, 2024, 14:10
Oct 27, 2024, 13:54
Oct 27, 2024, 13:50
Oct 27, 2024, 13:38
Oct 27, 2024, 13:07